Conference
A Phase 2 biomarker-enriched study of evofosfamide (TH-302) in patients with advanced melanoma.
Authors
McWhirter E; Hamid O; Chmielowski B; Carvajal RD; Jaffray DA; Driscoll B; Shek T; Yeung I; Keller H; McKee TD
Volume
33
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Publication Date
May 20, 2015
Name of conference
51st Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer
Conference place
IL, Chicago
Conference start date
May 29, 2015
Conference end date
June 2, 2015
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
15
ISSN
0732-183X